Continuous Regulatory Intelligence: Your Edge in a Regulated Market
Continuous regulatory intelligence enables proactive tracking of FDA and Health Canada updates, reducing risk, accelerating approvals, and sustaining competitive advantage.…
Medical Device Licensing in Canada and the US: A Step-by-Step Guide to MDEL/MDL, FDA 510(k), De Novo, and PMA
This guide details Canadian (MDEL/MDL) and US (FDA 510(k), De Novo, PMA) medical device licensing steps: classification, QMS, evidence, submissions,…
How to Ensure Cosmetic Ingredient Compliance With FDA MoCRA and Health Canada
This guide details FDA MoCRA and Health Canada cosmetic compliance, covering ingredient screening, labeling, safety, cross-border rules, and highlights Arora…
Navigating International Cosmetic Compliance: Common Challenges and Practical Solutions
This guide highlights challenges in international cosmetic compliance—US MoCRA, EU 1223/2009, Health Canada—and offers practical solutions like INCI labeling, claims…
Strategic Regulatory Guidance to Minimize Risk in Pharmaceutical Submissions (FDA and Health Canada)
Strategic regulatory guidance for FDA and Health Canada submissions emphasizes proactive planning, compliance, thorough data, and communication to reduce refuse-to-file…
Pharmaceutical Regulatory Wins: Three Anonymized Case Studies Across US FDA and Health Canada
Three pharma case studies show that strategic planning, expert regulatory meetings, and rigorous data integrity checks enable successful US FDA…
Navigating Regulatory Challenges for Cosmetic Products in North America: Your Guide to Compliance Success
This guide details North American cosmetic regulations, emphasizing FDA and Health Canada compliance for ingredients and labeling. Arora 297 Consultancy…
How to Build and Maintain a Quality Management System That Ensures Regulatory Success
Build and maintain a robust Quality Management System by understanding FDA and Health Canada regulations, documenting processes, training staff, conducting…
